2004 Conference Publication Anti-allodynic effects of Xen2174 in rats with neuropathy. AbstractSmith, M. T., Nielsen, C., Lewis, R., Alewood, D. and Drinkwater, R. D. (2004). Anti-allodynic effects of Xen2174 in rats with neuropathy. Abstract. ANZCA Annual Scientific Meeting, Perth, Western Australia, 1-5 May, 2004. Australia: ANZCA. |
2004 Conference Publication Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic painNielsen, C., Smith, M. T., Lewis, R., Alewood, D. and Drinkwater, R. D. (2004). Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. CPT2004: 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Qld, Australia, 1-6 August, 2004. Oxford, United Kingdom: Blackwell Scientific Publications. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
2004 Conference Publication Assessment of working spatial memory utilising T-maze and Morris water-maze for the study of a rodent model of alzheimer's diseasePatel, A., Smith, M. T. and Cabot, P. J. (2004). Assessment of working spatial memory utilising T-maze and Morris water-maze for the study of a rodent model of alzheimer's disease. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, 30 November - 1 December 2004. Brisbane: Qld Government. |
2004 Conference Publication Opioids and NMDA receptors: Neuro-excitation and abnormal pain behavioursSmith, M. T. (2004). Opioids and NMDA receptors: Neuro-excitation and abnormal pain behaviours. ANZCA Annual Scientific Meeting, Perth, 1-5 May 2004. Australia: ANZCA. |
2004 Conference Publication The pro-allodynic effects of morphine-3-glucuronide (M3G) appear to be opioid-receptor mediatedNielsen, C., De Cruz, S. E. and Smith, M. T. (2004). The pro-allodynic effects of morphine-3-glucuronide (M3G) appear to be opioid-receptor mediated. 25th Annual Scientific Meeting of the Australian Pain Society, Canberra, 7-10 March 2004. Australia: Australian Pain Society. |
2004 Conference Publication Comparative pharmacokinetics and metabolism of subcutaneous oxycodone in male dark agouti relative to sprague-dawley ratsHuang, L., Edwards, S. R. and Smith, M. T. (2004). Comparative pharmacokinetics and metabolism of subcutaneous oxycodone in male dark agouti relative to sprague-dawley rats. CTP 2004, Brisbane, 1-6 August 2004. Australia: Blackwell Publishing Asia. |
2003 Conference Publication Serum concentrations of metabolically-derived oxymorphone are insignificant in diabetic and non-diabetic adult male Dark Agouti rats following subcutaneous oxycodone bolus administration: Comparison with Sprague-Dawley ratsHuang, L., Le, L., Edwards, S. R. and Smith, M. T. (2003). Serum concentrations of metabolically-derived oxymorphone are insignificant in diabetic and non-diabetic adult male Dark Agouti rats following subcutaneous oxycodone bolus administration: Comparison with Sprague-Dawley rats. Annual Scientific Meeting of ASCEPT, Sydney, 30 November - 3 December 2003. Melbourne: ASCEPT. |
2003 Conference Publication A fresh approach to neuropathic pain management: From the animal model to the patientMoore, B., Azzopardi, J., Cabot, P. J., Gray, P., Roufogalis, B. and Smith, M. T. (2003). A fresh approach to neuropathic pain management: From the animal model to the patient. Combined meeting of the Australian Pain Society 24th ASM and New Zealand Pain Society 10th ASM, Christchurch, NZ, 9-13 March 2003. Sydney: Australian Pain Society. |
2003 Conference Publication Longitudinal investigation of the antinociceptive potency of oxycodone and morphine in the Zucker ratTsui, D. Y., Hawes, S., Patterson, M. and Smith, M. T. (2003). Longitudinal investigation of the antinociceptive potency of oxycodone and morphine in the Zucker rat. Annual Scientific Meeting of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 2003, Sydney, 30 November - 3 December 2003. Melbourne: ASCEPT. |
2003 Conference Publication Quantification of morphine, oxycodone, morphine-3-glucuronide and noroxycodone in rat serum by high performance liquid chromatography (HPLC-electrospray mass spectrometry (EMS)Edwards, S. R. and Smith, M. T. (2003). Quantification of morphine, oxycodone, morphine-3-glucuronide and noroxycodone in rat serum by high performance liquid chromatography (HPLC-electrospray mass spectrometry (EMS). Annual Scientific Meeting of ASCEPT 2003, Sydney, 30 November - 3 December 2003. Melbourne: ASCEPT. |
2002 Conference Publication In vivo investigation of the effects of intracerebroventricular (ICV) morphine-3-glucuronide (M3G) on von frey paw withdrawal thresholds in ratsLe, L., Hemstapat, K. and Smith, M. T. (2002). In vivo investigation of the effects of intracerebroventricular (ICV) morphine-3-glucuronide (M3G) on von frey paw withdrawal thresholds in rats. AHMR Congress 2002, Melbourne, 24-29 Nov. 2002. Melbourne: NHMRC. |
2002 Conference Publication Oxycodone, but not morphine, is efficacious for the relief of tactile allodynia in diabetic rats at three and six months after the induction of diabetes with streptozotocinLotfipour, S., Ross, F. B., Saini, K. and Smith, M. T. (2002). Oxycodone, but not morphine, is efficacious for the relief of tactile allodynia in diabetic rats at three and six months after the induction of diabetes with streptozotocin. 10th World Congress on Pain, San Diego, 17-22 Aug. 2002. Seattle: IASP Press. |
2002 Conference Publication Supraspinally administered oxycodone has intrinsic anti-allodynic effects for the alleviation of tactile allodynia in adult male rats with streptozotocin-induced diabetesSmith, M. T., Patterson, M. and Ross, F. B. (2002). Supraspinally administered oxycodone has intrinsic anti-allodynic effects for the alleviation of tactile allodynia in adult male rats with streptozotocin-induced diabetes. 10th World Congress on Pain, San Diego, 17-22 August 2002. Seattle: IASP Press. |
2002 Conference Publication Anti-allodynic efficacy of the conopeptide, MR1A, in rats with neuropathic painNielsen, C., Ross, F. B., Lewis, R. J., Drinkwater, R. D. and Smith, M. T. (2002). Anti-allodynic efficacy of the conopeptide, MR1A, in rats with neuropathic pain. 10th World Congress on Pain, San Diego, 17-22 Aug. 2002. Seattle: IASP Press. |
2002 Conference Publication Investigation of the role of dynorphin-A in mediating morphine-3-glucuronide's neuro-excitatory effectsHemstapat, K., Monteith, G. R. and Smith, M. T. (2002). Investigation of the role of dynorphin-A in mediating morphine-3-glucuronide's neuro-excitatory effects. 10th World Congress on Pain, San Diego, 17-22 Aug. 2002. Seattle: IASP Press. |
2002 Conference Publication Electrolyte removal from artificial CSF by HPLC to restore ESI-MS/MS signal intensity in quantification of morphine and its glucuronide metabolitesWells, J. A., Punjanon, T. and Smith, M. T. (2002). Electrolyte removal from artificial CSF by HPLC to restore ESI-MS/MS signal intensity in quantification of morphine and its glucuronide metabolites. 10th World Congress on Pain, San Diego, 17-22 Aug. 2002. Seattle: IASP Press. |
2002 Conference Publication Anti-allodynic efficacy of the x-conipeptide, MR1A, in rats with neuropathic painNielsen, C., Ross, F. B., Lewis, R. J., Drinkwater, R. D. and Smith, M. T. (2002). Anti-allodynic efficacy of the x-conipeptide, MR1A, in rats with neuropathic pain. AHMR Congress 2002, Melbourne, 24-29 Nov. 2002. Melbourne: NHMRC. |
2002 Conference Publication Prolonged oestradiol supplementation does not significantly alter levels of antinociception evoked by ICV morphine in adult male ratsMather, L. E., Punjanon, T. and Smith, M. T. (2002). Prolonged oestradiol supplementation does not significantly alter levels of antinociception evoked by ICV morphine in adult male rats. 10th World Congress on Pain, San Diego, 17-22 Aug. 2002. Seattle: IASP Press. |
2002 Conference Publication P/Q and L-type calcium channel blockers abolish morphine-3-glucuronide (M3G)-induced indirect activation of the NMDA receptorHemstapat, K., Monteith, G. R. and Smith, M. T. (2002). P/Q and L-type calcium channel blockers abolish morphine-3-glucuronide (M3G)-induced indirect activation of the NMDA receptor. AHMR Congress 2002, Melbourne, 24-29 Nov. 2002. Melbourne: NHMRC. |
2002 Conference Publication Serum 17 -oestradiol concentrations are directly correlated with the time to reach peak antinociception in oestradiol-pretreated rats administered prolonged intravenous morphine infusionsLe, L., Chmura, P., Mather, L. E. and Smith, M. T. (2002). Serum 17 -oestradiol concentrations are directly correlated with the time to reach peak antinociception in oestradiol-pretreated rats administered prolonged intravenous morphine infusions. 10th World Congress on Pain, San Diego, 17-22 Aug. 2002. Seattle: IASP Press. |